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CASE

REPORT

Secondary syphilis mimicking marginal zone
B-cell lymphoma
Emily Correia, BS,a Laura Gleason, BS,a Shalini Krishnasamy, MD,a,b Alexa Cohen, BS,a Safiyyah Bhatti, MD,a,b
and Neda Nikbakht, MD, PhDa
Philadelphia, Pennsylvania
Key words: B-cell lymphoma; clinicopathologic correlation; sexually transmitted diseases; syphilis.

INTRODUCTION
Syphilis is often referred to as the ‘‘great imitator,’’
as its clinical and histologic manifestations often
mimic other cutaneous diseases. The clinical presentation of secondary syphilis extends over a wide
spectrum of symptoms, including fever, malaise, and
generalized lymphadenopathy, as well as a broad
range of skin findings, including macular, papular,
lichenoid, nodular, and pustular lesions.1 Similar to
its clinical presentation, the histologic findings of
syphilis vary.2 As a result, accurate diagnosis of
atypical presentations of syphilis requires robust
clinicopathologic collaborations.

CASE REPORT
A 50-year-old Caucasian man was referred to a
cutaneous lymphoma clinic for evaluation of skin
involvement by marginal zone B-cell lymphoma
(MZL). The patient was originally assessed by
Hematology for intermittent episodes of fever, night
sweats, chills, fatigue, weight loss, lymphadenopathy, and a diffuse erythematous papular rash. Given
the concern for systemic malignancy, an oncology
workup, including imaging, blood work, and lymph
node and skin biopsies, was initiated. Positron
emission tomography and computed tomography
scans displayed diffuse hypermetabolic cervical,
axillary, and inguinal lymphadenopathy and hypermetabolic skin and subcutaneous lesions. The lymph
node biopsy revealed a reactive process, while skin
biopsies revealed MZL.
The skin biopsies demonstrated a dense, superficial, and nodular proliferation of lymphocytes
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Abbreviations used:
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marginal-zone B-cell lymphoma

and plasmacytoid cells that stained positive for
CD20, B-cell lymphoma 2, and CD79a (Fig 1). A
high Ki-67 proliferation index and lambda light
chain restriction were noted; immunoglobulin
heavy chain gene rearrangement analysis revealed
monoclonality of the infiltrate. Spirochete, periodic
acideSchiff, and acid-fast stains were negative.
These molecular findings raised concerns for
MZL and prompted the referral to the cutaneous
lymphoma clinic.
During the visit, the patient reported a 3-week
history of fever, night sweats, and a diffuse papular
rash that had not changed since his presentation
to Hematology. Physical exam revealed crusted
erythematous macules and papules diffusely scattered on the trunk, extremities, and face with
dusky macules on bilateral palms and soles
(Fig 2). He denied any additional symptoms or
the use of any medications, including antibiotics.
Even though the spirochete stain of the biopsy was
negative, given the strong clinical suspicion for
secondary syphilis, a rapid plasma reagent test was
performed.
The rapid plasma reagent test was positive with a
titer of 1:64, and the fluorescent treponemal antibody
absorption test was positive. A diagnosis of secondary syphilis was made, and the patient received a
penicillin injection (2,400,000 units/4 mL syringe).

JAAD Case Reports 2022;20:50-3.
2352-5126
Ó 2021 by the American Academy of Dermatology, Inc. Published
by Elsevier, Inc. This is an open access article under the CC BYNC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
https://doi.org/10.1016/j.jdcr.2021.11.026

JAAD CASE REPORTS

Correia et al 51

VOLUME 20

Fig 1. Dense, superficial, and nodular proliferation of lymphocytes and plasmacytoid cells (A,
Hematoxylin-eosin stain; original magnification: 340; Inset, 3100) that were CD201 (B,
Hematoxylin-eosin stain; original magnification: 340; Inset 3100) and BCL-21 (C,
Hematoxylin-eosin stain; original magnification: 340, Inset, 3100.) BCL-2, B-cell lymphoma 2.

Fig 2. Crusted erythematous macules and papules on the chest (A), back (B), bilateral palms
(C), and soles (D) were appreciated on initial presentation to Dermatology.

After receiving treatment, the patient’s fever, night
sweats, and rash subsided (Fig 3). He gained 4 kg
since treatment; his lymphadenopathy resolved clinically, and the resolution of lymphadenopathy was
confirmed by imaging. Three months later, a repeat
rapid plasma reagent test revealed a 4-fold decline in
the titer (1:4) demonstrating an appropriate response
to treatment.

DISCUSSION
This case demonstrates the importance of
analyzing the clinical presentation and histologic
findings together to accurately diagnose syphilis and
differentiate it from other inflammatory, infectious,
or malignant processes. In this case, secondary
syphilis was mistaken for MZL. Typically, MZL presents with a solitary or multifocal erythematous to
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Fig 3. Resolution of erythematous macules and papules on the chest (A), back (B), bilateral
palms (C), and soles (D) following treatment with penicillin.

violaceous papules, plaques, or nodules on the trunk
or extremities.3 Pathology reveals diffuse infiltrates
of atypical marginal zone B cells in the dermis and
subcutis with CD20, B-cell lymphoma 2, and CD79a
positivity and B-cell monoclonality.3 The patient’s
biopsy displayed similar findings with no evidence
of spirochetes. These histopathologic findings in
addition to the presence of so-called ‘‘B symptoms’’
and lymphadenopathy led to the diagnosis of MZL.
However, the clinical presentation of diffuse papular
rash involving the entire body, including the palms
and soles, did not match the typical clinical manifestations of MZL.
Although the patient’s biopsy was representative
of MZL, it is well known that histologic findings
associated with secondary syphilis are highly variable and nonspecific. Syphilis specimens have been
mistaken for mycosis fungoides, psoriasis, lichen
planus, reticulohistiocytomas, and pityriasis rosea.4
Similarly, syphilis has previously been reported to
histologically mimic lymphoid neoplasms.5-8 Most
recently, a study analyzed the histopathologic features distinguishing secondary syphilis from its

mimickers, but imitators of B-cell lymphomas were
lacking.2
While detection of a dominant B-cell clone can
indicate the presence of a B-cell malignancy, prominent B-cell clones may emerge in response to
antigen stimulation. Clonal B-cell proliferation may
ensue during the later stages of adaptive B-cell
immunity, and particularly when a restricted number
of epitopes are present on the eliciting antigens.
Indeed, monoclonal immunoglobulin heavy chain
gene rearrangements have been detected in cases of
exposure to both pathogenic or autoreactive antigens including Borrelia-associated infections, morphea, and Jessner lymphocytic infiltrate among
others.9
The B-cell clonality assay used in this case utilized
the BIOMED-2 protocol.10 This protocol has the
analytical sensitivity to detect 5% clonal cells in a
polyclonal background. In detecting B-cell lymphomas compared with benign lymphoid hyperplasia, its sensitivity ranges from 85% to 99%, and its
specificity ranges from 75% to 96%.10 It should be
noted that sensitivity and specificity calculations for
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this assay were limited by sample size and by
diversity of the benign conditions used as controls.
The limitations of clonality assays must be considered when interpreting the results. Most importantly,
a clinicopathologic interpretation is necessary to
determine whether clonal lymphocytes are malignant or reactive. In our case, the clonal B-cells
detected were likely reactive to an antigenic epitope
on the pathogenic spirochetes.
This case highlights the importance of collaboration between clinicians and pathologists to accurately diagnose syphilis. Estimates of the prevalence
and incidence of syphilis provided by the World
Health Organization demonstrate that syphilis remains an urgent public health issue.1 Clinicians and
pathologists alike should keep the possibility of this
disease in mind to achieve an accurate diagnosis due
to the clinical and histologic variations of the disease.
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1. Çakmak SK, Tamer E, Karada
g AS, Waugh M. Syphilis: a great
imitator. Clin Dermatol. 2019;37(3):182-191. https://doi.org/10.
1016/j.clindermatol.2019.01.007

Correia et al 53

2. Flamm A, Alcocer VM, Kazlouskaya V, Kwon EJ, Elston D.
Histopathologic features distinguishing secondary syphilis
from its mimickers. J Am Acad Dermatol. 2020;82(1):156-160.
https://doi.org/10.1016/j.jaad.2019.07.011
3. National Comprehensive Cancer Network. NCCN Guidelines
for Patients with Primary Cutaneous Lymphomas. 2021.
Accessed December 28, 2021. https://www.nccn.org/pati
ents/guidelines/content/PDF/pcl-patient.pdf
4. Jeerapaet P, Ackerman AB. Histologic patterns of secondary
syphilis. Arch Dermatol. 1973;107(3):373-377.
5. Moon HS, Park K, Lee JH, Son SJ. A nodular syphilid presenting
as a pseudolymphoma: mimicking a cutaneous marginal zone
B-cell lymphoma. Am J Dermatopathol. 2009;31(8):846-848.
https://doi.org/10.1097/DAD.0b013e3181ad4f22
6. Goffinet DR, Hoyt C, Eltringham JR. Secondary syphilis
misdiagnosed as lymphoma. Ariz Med. 1970;27(5):22-23.
7. Erfurt C, Lueftl M, Simon M Jr, Schuler G, Schultz ES. Late
syphilis mimicking a pseudolymphoma of the skin. Eur J
Dermatol. 2006;16(4):431-434.
8. Hodak E, David M, Rothem A, Bialowance M, Sandbank M.
Nodular secondary syphilis mimicking cutaneous lymphoreticular process. J Am Acad Dermatol. 1987;17(5 Pt 2):914-917.
https://doi.org/10.1016/s0190-9622(87)70280-1
9. Sproul AM, Goodlad JR. Clonality testing of cutaneous
lymphoid infiltrates: practicalities, pitfalls and potential uses.
J Hematopathol. 2012;(5):69-82. https://doi.org/10.1007/s123
08-012-0145-9
10. Raess PW, Bagg A. The role of molecular pathology in the
diagnosis of cutaneous lymphomas. Patholog Res Int. 2012;
2012:913523. https://doi.org/10.1155/2012/913523

